Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review

被引:398
作者
Soleimani, Vahid [1 ]
Sahebkar, Amirhossein [2 ]
Hosseinzadeh, Hossein [3 ]
机构
[1] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Iran
[2] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Iran
[3] Mashhad Univ Med Sci, Sch Pharm, Dept Pharmacodynam & Toxicol, Mashhad, Iran
关键词
clinical trial; Curcuma longa; curcumin; safety; toxicology; turmeric; QUALITY-OF-LIFE; DOUBLE-BLIND; KNEE OSTEOARTHRITIS; CLINICAL-TRIAL; SYSTEMIC INFLAMMATION; PREMENSTRUAL-SYNDROME; ALZHEIMERS-DISEASE; ORAL CURCUMIN; ESSENTIAL OIL; SOLID TUMORS;
D O I
10.1002/ptr.6054
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Curcumin is the major constituent of turmeric (Curcuma longa). Turmeric has been widely used as a spice in foods and for therapeutic applications such as anti-inflammatory, antihyperlipidemic, and antimicrobial activities. Turmeric and curcumin are nonmutagenic and nongenotoxic. Oral use of turmeric and curcumin did not have reproductive toxicity in animals at certain doses. Studies on human did not show toxic effects, and curcumin was safe at the dose of 6g/day orally for 4-7weeks. However, some adverse effects such as gastrointestinal upsets may occur. Moreover, oral bioavailable formulations of curcumin were safe for human at the dose of 500mg two times in a day for 30days, but there are still few trials and more studies are needed specially on nanoformulations and it should be discussed in a separate article. In addition, curcumin is known as a generally recognized as safe substance. This review discusses the safety and toxicity of turmeric and curcumin in medicine. Turmeric and curcumin are nontoxic for human especially in oral administration. Turmeric and curcumin are also safe in animals. They are nonmutagenic and are safe in pregnancy in animals but more studies in human are needed.
引用
收藏
页码:985 / 995
页数:11
相关论文
共 106 条
[1]   Efficacy of turmeric (curcumin) in pain and postoperative fatigue after laparoscopic cholecystectomy: a double-blind, randomized placebo-controlled study [J].
Agarwal, Krishna Adit ;
Tripathi, C. D. ;
Agarwal, Brij B. ;
Saluja, Satish .
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2011, 25 (12) :3805-3810
[2]  
Aggarwal BB, 2007, ADV EXP MED BIOL, V595, P1
[3]   Systematic and comprehensive investigation of the toxicity of curcuminoid-essential oil complex: A bioavailable turmeric formulation [J].
Aggarwal, Madan L. ;
Chacko, Karampendethu M. ;
Kuruvilla, Binu T. .
MOLECULAR MEDICINE REPORTS, 2016, 13 (01) :592-604
[4]   The Anti-Inflammatory and Antioxidant Effects of Curcumin in Middle Ear Infection [J].
Akyuz, Servet ;
Turany, Fatih ;
Gurbuzler, Levent ;
Arici, Akgul ;
Sogut, Erkan ;
Ozkan, Ozalkan .
JOURNAL OF CRANIOFACIAL SURGERY, 2016, 27 (05) :E494-E497
[5]   The Role of Curcumin Administration in Patients with Major Depressive Disorder: Mini Meta-Analysis of Clinical Trials [J].
Al-Karawi, Dalia ;
Al Mamoori, Doaa Alem ;
Tayyar, Yaman .
PHYTOTHERAPY RESEARCH, 2016, 30 (02) :175-183
[6]   Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies [J].
Allegra, Alessandro ;
Innao, Vanessa ;
Russo, Sabina ;
Gerace, Demetrio ;
Alonci, Andrea ;
Musolino, Caterina .
CANCER INVESTIGATION, 2017, 35 (01) :1-22
[7]   PHARMACOLOGY OF CURCUMA-LONGA [J].
AMMON, HPT ;
WAHL, MA .
PLANTA MEDICA, 1991, 57 (01) :1-7
[8]   Bioavailability of curcumin: Problems and promises [J].
Anand, Preetha ;
Kunnumakkara, Ajaikumar B. ;
Newman, Robert A. ;
Aggarwal, Bharat B. .
MOLECULAR PHARMACEUTICS, 2007, 4 (06) :807-818
[9]   Principles of pharmacological research of nutraceuticals [J].
Andrew, Ruth ;
Izzo, Angelo A. .
BRITISH JOURNAL OF PHARMACOLOGY, 2017, 174 (11) :1177-1194
[10]  
[Anonymous], J TRADIT COMPLEMENT